å»è¬åå ¬è¡šãããæŽå¯
é¢ç¯çãé垯ãçèãè ±ãäœã®äžéšã®èåšã®ã»ãšãã©ãäœã®æ¯æãŸãã¯æ¥ç¶æ§é ã«åœ±é¿ãåãŒããŸãã ãã®ç æ°ã¯é¢ç¯ã®ççã«ãã£ãŠç¹åŸŽä»ããããããã¯ããã€ãã®ã¿ã€ãã®ãªã¥ãŒããããžãŒçŸæ£ã®èæ€ã«åœ±é¿ãäžããŸãã 100çš®é¡ä»¥äžã®æ ¢æ§çŸæ£ããããŸãã é£ç掻ãçæŽ»ã®å€åãªã©ãããŸããŸãªéºäŒçããã³ç°å¢èŠå ã«ãã£ãŠåŒãèµ·ããããŸãã Osteoarthritisã®ç¹é·, èé«èç, é¢ç¯ãªãŠãã, ç颚æ§é¢ç¯ç, åå¿æ§é¢ç¯ç, ç·ç¶ççç, ç®èè «ã¯ãé¢ç¯ççŸæ£ã®äžè¬çãªã¿ã€ãã®ããã€ãã§ã. Rheumatologyã®åŠçœ®ã¯æ¥åç®æã®æå·ãæ²»ãããã«å€ç§åŠçœ®ã®è¬ç©ãç·Žç¿ããã³ç©ççãªçæ³ã䌎ããŸãã... ãã£ãšèŠã
ã¬ã³ããç ã¯ãæææ§èè±çŸæ£(IBD)ãšãåŒã°ããäž»ã«é¶ã®å ç«ç³»ãæšçããææçãŠã€ã«ã¹(IBDV)ã«ãã£ãŠåŒãèµ·ãããããŠã€ã«ã¹æ§çŸæ£ã§ãã ãã®ç æ°ã¯å ç«æå¶ãšèªçºãããŠããªãäžé¢é³¥ãšã¢ãã«ã®éã§åºãæ®åããŠããŸãã ã¬ã³ããç ã¯3é±éœ¢ãããå€ãé¶ã§çºçããé«åºŠã«äŒææ§çŸæ£ã§ãã ç æ°ã¯ããã§ã¹ãšããã€ãã®å°¿è·¯ãããªã«ã®çŸœæ ¹ããã¯ã¿ãŒã«ã倪ããè ¹çã«ãããææ°Žçããªãã³ã«æ ¢æ§å°¿è·¯éæã«ããè èãæãªããªã©ãããŸããŸãªçç¶ã«é¢é£ããŠããŸãã å¯èšåºææçã¯ãæææ§æ°ç®¡æ¯çããã¥ãŒã«ãã¹ã«ç ããã¬ãŒã¯ç ã«å¯Ÿããå ç«åå¿ã®æ¬ ä¹çã«åãŒãã ãã§ãªããæŽåæ§ç®èçããã³äŸµå ¥äœèçã«å¯Ÿããæåæ§ãé«ã... ãã£ãšèŠã
ã±ã³ãã§ããŒã«åžå ŽãçŽåºŠå¥ïŒ98ïŒ ä»¥äžã95ïŒ ïœ98ïŒ æªæºã95ïŒ æªæºïŒãäŸçµŠæºå¥ïŒå€©ç¶æ€ç©ç±æ¥ãåæïŒãçšéå¥ïŒå»è¬åããã³ã©ã€ããµã€ãšã³ã¹ç ç©¶ãæ é€è£å©é£åãé£åããã³é£²æãåç²§åããã³ããŒãœãã«ã±ã¢ãåæåºæºããã³æ€æ»ããã®ä»ïŒãæµéãã£ãã«å¥ïŒçŽæ¥è²©å£²ãéæ¥è²©å£²ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ã ãããŠã¢ããªã«ïŒ... ãã£ãšèŠã
å€émyelomaã¯æªæ§è¡æŒ¿çްèã«ãã£ãŠåœ¢æãããçã®åœ¢æ ã§ãã æªæ§è «çã¯ãè¡æµã埪ç°åšç³»ããªã³ãç³»ãä»ããéåžžã«äžå®å®ãªç°åžžçްèãã圢æãããŸãã è¡æŒ¿çްèã¯ãããããã³ç²æ§çã«å¢æ®ãã骚é«ãå¥åº·ãªè¡æ¶²çްèãå ç«ã°ãããªã³ãäœãåºãã®ãé²ãè¡æŒ¿çްèè «ãšåŒã°ããè «çãäœãåºããŸããmyeloma现èã®åœ¢æããã³å¢æ®ã¯å°æ°ã®leukocyteãerythrocyteããã³è¡å°æ¿çްèã®åœ¢æã«ãã£ãŠæãªãããå ç«ã·ã¹ãã ãåŒãèµ·ãããŸãã æ¶å管ã®åé¡ãæ¡å€§ãããåšå®ãè èã®æå·ãæ¥éãªæžéã骚ã®èŠçããã³ç±ã¯è€æ°ã®myelomaã®å ±éã®åŸŽåã®ããã€ãã§ãã è€æ°ã®myelomaã¯ããªã³ãè «ãšçœè¡... ãã£ãšèŠã
çŸå®¹ããã³ã¹ãã³ã±ã¢æ é€è£å©é£ååžå Žã補åã¿ã€ãå¥ïŒã³ã©ãŒã²ã³ããŒã¹ã¿ãŒ/ãµããªã¡ã³ãããªã¡ã¬èèªé žãæé žåç©è³ªããã¿ãã³ããã³ããã©ã«ããããã€ãªãã£ã¯ã¹ããã®ä»ïŒãçš®é¡å¥ïŒåæã倩ç¶/ãªãŒã¬ããã¯ïŒãã«ããŽãªãŒå¥ïŒããŒããµããªã¡ã³ããéããŒããµããªã¡ã³ãïŒã圢æ å¥ïŒé å€ããã³ã«ãã»ã«/ãœãããžã§ã«ãç²æ«ãæ¶²äœãã°ãããã®ä»ïŒãçšéå¥ (ã¢ã³ããšã€ãžã³ã°/æã·ã¯ãè²çŽ æ²çéå°ãããããšå·ã®ã³ã³ãããŒã«ãèã®çŸçœãšåŒãç· ããèã®æ°Žåè£çµŠãæ¥çŒãæ¢ããšä¿®åŸ©ãè§£æ¯ãéæçããã®ä»)ã販売ãã£ãã«å¥ (ãªã³ã©ã€ã³ããªãã©ã€ã³)ãå°åå¥ (åç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«... ãã£ãšèŠã
çèçž®æ§åŽçŽ¢ç¡¬åçïŒALSïŒåžå Žãè¬å€ã¿ã€ãå¥ïŒãã§ãã«é ªé žãããªãŠã ããã³ã¿ãŠã«ã«ãœãžãªãŒã«ããšãã©ãã³ãããšãã¯ã¹ã¿ãããã§ã«ã»ã³ããªã«ãŸãŒã«ãçåŒç·©è¬ãéã¹ããã€ãæ§æççè¬ïŒNSAIDïŒããã®ä»ïŒãæäžçµè·¯å¥ïŒçµå£ãéçµå£ããã®ä»ïŒãå€åœ¢å¥ïŒçµå£æžæ¿æ¶²ã泚å°å€ã é å€ããã®ä»ïŒãæµéãã£ãã«å¥ïŒç é¢è¬å±ããªã³ã©ã€ã³è¬å±ãå°å£²è¬å±ïŒãå°åå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«ïŒ... ãã£ãšèŠã
äžå®ãšæãã€ã¯ã倧è¡ãäžçäžã§åœ±é¿ãåãã粟ç¥ç§çŸæ£ã®æãäžè¬çãªåœ¢æ ã§ããããšãç¥ãããŠããŸãã ãåãåãã ããã¬ãã·ã§ã³ äžçã®äººå£ã«ééãã粟ç¥éå®³ã®æãäžè¬çãªã¿ã€ãã§ãããäžå®ã¯ã¹ãã¬ã¹ã®å€ãç¶æ³ã®äžã§åã ã®åå¿ãæããŸãã äžå®é害ã¯ãéåžžã®å¿é ãææä»¥äžã®ãã®ã§ãã äžå®ã«èŠããã§ãã人ã®ããã«ãåäººã®æªæ§çžã¯æéããããŠäžãã代ããã«æªåããŸããã ãã®äžå®ãªé害ã¯ãåŠæ ¡ã®ä»äºãé¢ä¿ãä»äºã®ããã©ãŒãã³ã¹ãªã©ã®æ¯æ¥ã®æŽ»åã«åœ±é¿ãäžããããšãã§ããŸãã äžå®é¢é£ã®é害ã«ã¯ãäžè¬çãªäžå®é害ã瀟äŒäžå®é害ããããã¯é害ãªã©ããããŸãã ãŸãããã€ç ã¯äžè¬çãªãæ·±å»ãªæ°åé害ãæ... ãã£ãšèŠã
åœç«è¡çç ç©¶æ(NIH)ã«ãããšã2012幎ã«èªå·±å ç«çŸæ£ã«èŠããã§ããçŽ23.5äžäººã®ã¢ã¡ãªã«äººãããã ãŸãã2017幎ãå¥åº·ã»äººéãµãŒãã¹éšéã§ã¯ãèªå·±å ç«çŸæ£(AID)ã人æ°ã®å¥åº·ãããã¯ã®ããã10ãªã¹ãã«ã©ã³ã¯ãããŠãããšå ±åããã èªå·±å ç«çŸæ£ã¯ãå¿èãè³ãè èãè ºãç¥çµãªã©ã®èº«äœã®ç°ãªãéšåã§ããŸããŸãªå䜵çã«ã€ãªããå¯èœæ§ãããå¥åº·ã«æ·±å»ãªåœ±é¿ãæã£ãŠããŸãã èªå·±å ç«çŸæ£ã®å¢å çã¯ãäž»ã«æ 逿åãæ¯æ§ååŠç©è³ªãææçãå«ãéºäŒçããã³ç°å¢èŠå ã«ãããã®ã§ãã èªå·±å ç«çŸæ£ã«ã¯ãççæ§è žçŸæ£(IBD)ãé¢ç¯ãªãŠãã(RA)ãå€çºæ§åè硬åç(MS)ãã»ãªã¢ãã¯ç (CD)ãèç... ãã£ãšèŠã
ã€ã³ãçµå£åºåœ¢è£œå€åžå Žãå€åœ¢å¥ïŒé å€ããã³ã«ãã»ã«ïŒãè¬å€ã¯ã©ã¹å¥ïŒæååºè¬ãå¶åè¬ãæææçè¬ãæçç©è³ªãçåŒç·©è¬ããªããªã€ããªã©ïŒãçšéå¥ïŒå¿è¡ç®¡çŸæ£ãæŽåœ¢å€ç§ãæ¶ååšçŸæ£ãç³å°¿ç ãç¥çµç§ãè èç§ãè «çåŠãææçãªã©ïŒãæµéãã£ãã«å¥ (ç é¢è¬å±ãå°å£²è¬å±ããªã³ã©ã€ã³è¬å±)... ãã£ãšèŠã
ã³ãã€ã³ã¯ããªããªã€ããšããŠç¥ãããã¯ã©ã¹ã®è¬ç©ã§ããã軜床ããäžç床ã®çã¿ãæ¿ããçã¿ã也ããåºæ¿æ§ã®å³ãäžç¢ã颚éªãã€ã³ãã«ãšã³ã¶ïŒæãã¹ã¿ãã³è¬ã鬱è¡é€å»è¬ãšäœµçšããå ŽåïŒã®æ²»çã管çã«åºã䜿çšãããŠããããªããªã€ãã¯è³å ã®ãªããªã€ãå容äœãšçžäºäœçšããé®çããªã©ãã¯ã¹ãå¿«æãå è¶³æãªã©ã®äœçšãåŒãèµ·ãããã³ãã€ã³ã¯é垞飲ã¿èŸŒãŸããé å€ãã«ãã»ã«ã溶液ïŒã·ããããªã©ããŸããŸãªåœ¢æ ãããã ã³ãã€ã³åžå Žã®ä¿é²èŠå ã³ãã€ã³ã¯çã¿ãå³ã®æ²»çã»ç®¡çã«åºã䜿çšãããŠãããåç±³ãã¢ãžã¢å€ªå¹³æŽå°åãªã©ã®äž»èŠå°åã§ã¯ãé«éœ¢åãé²ãã§ãããããçã¿ã®æç çãé«ããã³ãã€ã³è£œå€ã®éèŠãå€§å¹ ã«å¢å ããäº... ãã£ãšèŠã
Leishmaniasisã¯ææã«ãã£ãŠåŒãèµ·ãããã麻è¬ã®ç æ°ã§ã ã¬ãã·ã¥ãã㢠å¯çè«ãšææãã女æ§ã®ãã§ãããã³ç ã®ããšã®å¬å·ãéããŠéä¿¡ã äžçä¿å¥æ©é¢(WHO)ã«ãããšãçŽ7,00,000ãã1,000,000ã®æ°çäŸãš20,000ã30,000ã®æ»äº¡ã¯ãã¬ãã·ã¥ããã¢çã®ããã«æ¯å¹ŽçºçããŸãã 3ã€ã®åœ¢æ ã®leishmaniasisã¯æ£åŒã«mucocutaneousleishmaniasisãvisceralã®leishmaniasisããã³cutaneousleishmaniasisã§ãã ãŽã£ãµãŒã«ã»ã¬ãã·ã¥ããã¢ã·ã¹(VL)ã¯ãä»ã®2çš®é¡ã®ã¬ãã·ã¥ããã¢çã®äžã§æãæ·±å»ãªç¶... ãã£ãšèŠã
å€åœ¢æ§èé¢ç¯çåžå Žãè¬å€ã¿ã€ãå¥ïŒãã¢ã«ãã³é žãéã¹ããã€ãæ§æççè¬ïŒNSAIDïŒãé®çè¬ãã³ã«ãã³ã¹ããã€ãããã®ä»ïŒãæäžçµè·¯å¥ïŒçµå£ãéçµå£ããã®ä»ïŒãæµéãã£ãã«å¥ïŒç é¢è¬å±ãå°å£²è¬å±ããªã³ã©ã€ã³è¬å±ïŒãå°çå¥ïŒåç±³ããšãŒããããã¢ãžã¢å€ªå¹³æŽãã©ãã³ã¢ã¡ãªã«ãäžæ±ãã¢ããªã«ïŒ... ãã£ãšèŠã
ã¢ãŒã©ã€ã³é žåžå ŽèŠæš¡ã¯ã2025幎ã®210.3çŸäžç±³ãã«ãã2032幎ã«ã¯358.1çŸäžç±³ãã«ã«éãããšäºæž¬ãããäºæž¬æéäžã®CAGRã¯7.9%ã§ãããã¢ãŒã©ã€ã³é žã¯ãæççäœçšãšæèäœçšãæã€å€©ç¶ç±æ¥ã®é žã§ããããã®é žã¯ãã³ã¡ãåè§£äœçšãè§è³ªæº¶è§£äœçšãæé žåäœçšããããããé ããã«ãã³ãªã©ã®ç®èçŸæ£ã®æ²»çã«äœ¿çšããããã¢ã±ã¢è£œåã«ããèŠããããã¢ãŒã©ã€ã³é žåžå Žã®å°åå¥ã€ã³ãµã€ãïŒ åç±³ã¯ã¢ãŒã©ã€ã³é žã®æå€§åžå Žã§ããã2025幎ã«ã¯38.7%ã®åžå Žã·ã§ã¢ãå ããç±³åœã¯å€§æäŒæ¥ã®ååšã«ããäºæž¬æéäžã®åžå Žæé·ã«å€§ããè²¢ç®ããŠãããåå°åã®æé·ãçœåŒããŠããã®ã¯ãæ¥çŒãæ¢ãå€ã®äœ¿çšæ¡å€§ãåç²§åæ¥... ãã£ãšèŠã
Pelargonic é žåžå Žã¯ USD 224.7 ã§è©äŸ¡ããããšæšå®ãããŸã 2025幎ã®Mnã¯USD 353.8ã«éãããšäºæ³ããã 2032幎ã2025幎ãã2032幎ã«ãããŠ6.7%ã®ååç©å¹Žéæé·ç(CAGR)ãå±ç€ºãã°ããŒãã«ãã©ãŒã®ãªã³é žåžå Ž - ã³ãããŠã€ã«ã¹ã®åœ±é¿(COVID-19)ãã³ãããã¯COVID-19 ã¯ãäžçç㪠pelargonic é žåžå Žã«å€§ããªåœ±é¿ãäžããŸããã äžåœãç±³åœãã€ã¿ãªã¢ãã€ã³ããå«ãäž»èŠãªåœã暪æããããã¯ããŠã³ã®åœ±é¿ã¯ãäžçåå°ã®ãµãã©ã€ãã§ãŒã³ã«æ··ä¹±ããããããŸããã ããã«ãã³ãããŠã€ã«ã¹ã®ç Žå£ã®åœ±é¿ãã³ã³ãããŒã«ããããã«ãããŸããŸãªåœ... ãã£ãšèŠã
Systemic Lupus Erythematosus(SLE)ã¯ãæ ¢æ§èªå·±å ç«é害ã§ãã äœã®çްèãéèŠãªèåšãæ»æããæäœã®éå°ãªçç£ã«ãã£ãŠç¹åŸŽä»ããããŸãã ç æ°ã«é¢é£ããããŸããŸãªçç¶ã«ã¯ãé¢ç¯ã®çã¿ãè «ããé¡ã®çºç¹(ãã¿ãã©ã€çºç¹)ããã³ä»ã®äœé åãé床ã®ç²åŽãæ¯æå€±ãè²§è¡ãããã³Raynaudã®çŸè±¡ãªã©ãå«ãŸããŸãã SLEã¯ãå¿èãè èãèºãè¡åã®å€åãªã©ã®éèŠãªäœåšå®ã«ã圱é¿ãåãŒãå¯èœæ§ããããŸãã ç æ°ã®æ£ç¢ºãªåå ã¯äžæã§ãããéºäŒçããã³ç°å¢çèŠå ã¯SLEã«ã€ãªããå¯èœæ§ããããŸãã SLEã«ã¯çŽæ¥æ²»çã¯ãããŸããããçç¶ã®æ²»çã¯ãç æ°ã«é¢é£ããçç¶ãäœäžãŸãã¯æé€ã... ãã£ãšèŠã
Tinnitusã¯ãå€éšãœãŒã¹ããæ¥ãŠããªãè³ã«äžå®ã®é³ã§ãã é³ã®æ§è³ªã¯ããªã³ã°ãããºãããŒã¢ãªã³ã°ãã¯ãªãã¯ãããŸããŸãªåŒ·åºŠã§åœŒã®æãããšã®å¯èœæ§ããããŸãã Tinnitusã¯ç æ°ã§ã¯ãªãçç¶ã§ãã è³é³Žãã®æ£ç¢ºãªç çåŠã¯ãŸã äžæã§ãããè³é³Žãã®ããŸããŸãªåå ã¯ãéšåçãªèŽèŠåªå€±ã倧ããªéšé³ãè³é³Žãããã®è³é³Žãã®éå¡ã骚ç²é¬ç(äžè³éªšã®åºå®)ãé éšã®å·å®³ããã³èžè³ç¥çµãªã©ã®æå·ã§ãã Tinnitusã¯ç掻ã®è³ªã«åœ±é¿ãåãŒããã¹ãã¬ã¹ã鬱ç ãéäžåäžè¶³ã«ã€ãªããå¯èœæ§ããããŸãã è³é³Žãçã¯æ²»ççæ³ãæã£ãŠããŸããããã¢ã¡ãªã«ã®è³é³ŽãåäŒã«ãããšãè³é³Žãçã®æ³šæçãææ çãèªç¥ç圱é¿ã«å¯Ÿ... ãã£ãšèŠã
ã¢ã¢ãšãããã£ãã¯æšªã®èæ±åŽåŒ¯ç(ALS)ã¯ãã©ãŠã»ã²ãªã°ç ãšã¢ãŒã¿ãŒãã¥ãŒãã³ç (MND)ãšãåŒã°ããè³å ã®ç¥çµçްèã«åœ±é¿ãåãŒããèªçºçãªçèãå¶åŸ¡ããèé«ã«åœ±é¿ãäžããç¥çµç³»çŸæ£ã§ãã ç æ°ã¯èªç¶ã®äžã§é²æ©çã§ãããæéããããŠæªåããããšãæå³ããŸãã2016幎ãç±³åœã«ãããALSããã³ALSã®æ®åçã¯ã2012幎10äžäººããã4.7çäŸã§ããã å¹³åå€ã10äžäººããã5.0çäŸã«å¢å ããåç ç©¶ã«ãããšã2013幎ã«ALSãšèšºæããã15,908人ååŸã«å¢å ããŸããã ALSã®å¢å€§çã¯ãè¿ãå°æ¥ãã¢ããã£ãã¯ãªæšªæ§èæ±åŽåŒ¯ç(ALS)æ²»çåžå Žã®æé·ããµããŒããããšæåŸ ãããŠããŸããæ°èŠ... ãã£ãšèŠã
ã¢ã«ããã€ããŒç (AD)ã¯ãèšæ¶ãæèãèšèªãè¡åã«åœ±é¿ãäžããèªç¥çã®äžçš®ã§ãã ã¢ã«ããã€ããŒç ã®å¹Žéœ¢ãé«éœ¢åã«èŠãã人ãå¢ãã65æ³ä»¥äžã¯ããã®é害ã®é²è¡ã«å€§ããªå±éºå åã§ãã 軜床ã®çç¶ã§å§ãŸããé床ã®è³æå·ã§çµãããšãå人ãäŒè©±ãéã¶èœåã倱ããç°å¢ã«åå¿ããã ã¢ã«ããã€ããŒåäŒã«ãããšã2017幎ãã¢ã«ããã€ããŒã®èªç¥çã«èŠããã§ãã5å以äžã®ã¢ã¡ãªã«äººãããŸãã æšå® 5.3 äžäººã¯65æ³ä»¥äžã20äžäººã®å人ã65æ³æªæºã§ãã¢ã«ããã€ããŒã®çºççã¯65æ³ä»¥äžã§ãã ã¢ã«ããã€ããŒã®èªç¥ããã³è¡åçç¶ã¯ãéè¬ç©æ²»çããã³å¯ŸçããŒã¹ã®è¬ã䜿çšããŠæ²»çããããšãã§ããŸãã ããããã¢... ãã£ãšèŠã